1026484-18-3

Basic information

• Product Name: 3-[2-(8-oxo-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethoxy]-benzoic acid methyl ester
• CAS NO: 1026484-18-3
• Molecular Weight: 328.327
• Mol File: 1026484-18-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[2-(8-oxo-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethoxy]-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2-(8-oxo-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethoxy]-benzoic acid methyl ester(1026484-18-3)
• EPA Substance Registry System: 3-[2-(8-oxo-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethoxy]-benzoic acid methyl ester(1026484-18-3)

Safety Data

• Hazardous Substances Data: 1026484-18-3(Hazardous Substances Data)

Upstream product

• 19438-10-9 methyl 3-hydroxybenzoate 
• 72079-77-7 6,7-dihydroimidazo<4,5-d><1,3>diazepin-8(3H)-one 
• 59516-96-0 1-Bromo-2-(3'-carbomethoxyphenoxy)ethane 

Downstream Products

• 165801-78-5 3-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethoxy]-benzoic acid methyl ester 

Relevant articles and documents

AMP deaminase inhibitors. 3. SAR of 3-(carboxyarylalkyl)coformycin aglycon analogues

N3-Substituted coformycin aglycon analogues with improved AMP deaminase (AMPDA) inhibitory potency are described. Replacement of the 5-carboxypentyl substituent in the lead AMPDA inhibitor 3-(5-carboxypentyl)-3,6,7,8- tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (2) described in the previous article with various carboxyarylalkyl groups resulted in compounds with 10- 100-fold improved AMPDA inhibitory potencies. The optimal N3 substituent had m-carboxyphenyl with a two-carbon alkyl tether. For example, 3-[2-(3-carboxy- 5-ethylphenyl)ethyl]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (43g) inhibited human AMPDA with a K(i) = 0.06 μM. The compounds within the series also exhibited > 1000-fold specificity for AMPDA relative to adenosine deaminase.